Clinical TrialsSearch results
Number of results: 314
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10
Other
- Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
- Acute Lymphoblastic Leukemia
- Tokyo Children's Cancer Study Group
- 2008-10-05
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of cisplatin and pemetrexed in previously treated patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Hyogo College of Medicine
- 2008-01-04
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Pegylated IFN alpha-2b/Ribavirin therapy for chronic hepatitis C with genotype Ib, high titer-analysis with viral clearance.
- Chronic hepatitis C
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine
- 2005-09-12
Other
- PEARL Study(PITAVASTATIN HEART FAILURE Study)
- Chronic heart failure
- Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
- 2006-06-09
Other
- Outcome study of hormonal therapy for prostate cancer in Japan
- Prostate cancer
- J-CaP study group
- 2005-09-29
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31